Vagus Nerve Stimulation.

Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders. Cell Mol Life Sci (2016) 0.88

Vagal nerve stimulation therapy: what is being stimulated? PLoS One (2014) 0.81

Continuous intraoperative monitoring of vagus and recurrent laryngeal nerve function in patients with advanced atrioventricular block. Langenbecks Arch Surg (2016) 0.79

Neuroimmune Control of Acute Kidney Injury and Inflammation. Nephron (2015) 0.78

The pig as preclinical model for laparoscopic vagus nerve stimulation. Int J Colorectal Dis (2015) 0.76

Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression. Neuroimage Clin (2016) 0.75

Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures. Neuropsychiatr Dis Treat (2014) 0.75

Human vagus nerve branching in the cervical region. PLoS One (2015) 0.75

Targeting neural reflex circuits in immunity to treat kidney disease. Nat Rev Nephrol (2017) 0.75

Trigeminal nerve stimulation modulates brainstem more than cortical excitability in healthy humans. Exp Brain Res (2015) 0.75

Cholinergic Modulation of the Immune System Presents New Approaches for Treating Inflammation. Pharmacol Ther (2017) 0.75

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 4.95

Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med (2002) 4.10

Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res (2002) 3.27

Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J (2010) 2.86

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry (2013) 2.68

Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med (2007) 2.41

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry (2005) 2.24

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15

Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther (2011) 2.12

The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med (2011) 2.08

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry (2005) 1.90

Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry (2013) 1.80

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry (2000) 1.61

The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59

Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines. Circulation (2011) 1.58

Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry (2005) 1.57

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology (2001) 1.51

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry (2005) 1.48

Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Hypertension (2012) 1.45

Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. Heart Fail Rev (2011) 1.37

Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry (2010) 1.37

Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry (2006) 1.33

BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm (Vienna) (2007) 1.31

Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia (2012) 1.31

Depression and cardiac disease: a review. Cardiol Rev (2011) 1.28

Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2013) 1.19

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry (2002) 1.17

Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia (1993) 1.09

Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil (2013) 1.09

The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol (2013) 1.09

Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm (2012) 1.09

Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med (2008) 1.09

Arrhythmias and vagus nerve stimulation. Heart Fail Rev (2011) 1.07

Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs (2009) 1.06

Kapalabhati--yogic cleansing exercise. II. EEG topography analysis. Homeost Health Dis (1991) 1.06

Transcutaneous vagus nerve stimulation for the treatment of depression: a study protocol for a double blinded randomized clinical trial. BMC Complement Altern Med (2012) 1.04

Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS One (2012) 1.03

[A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI]. Biomed Tech (Berl) (2008) 1.03

The chemical neuroanatomy of vagus nerve stimulation. J Chem Neuroanat (2010) 1.01

Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study. J Neural Transm (Vienna) (2012) 0.99

Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol (2010) 0.98

Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept. Childs Nerv Syst (2000) 0.97

CNS BOLD fMRI effects of sham-controlled transcutaneous electrical nerve stimulation in the left outer auditory canal - a pilot study. Brain Stimul (2013) 0.96

Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats. Biol Psychiatry (2011) 0.96

Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia: an unlikely role for cerebral blood flow. Brain Res (2011) 0.95

Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul (2012) 0.95

Does the vagus nerve mediate the sixth sense? Trends Neurosci (2001) 0.93

Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res (2011) 0.92

Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs. Eur Psychiatry (2011) 0.91

Depression as an evolutionary strategy for defense against infection. Brain Behav Immun (2012) 0.91

The effect of transcutaneous vagus nerve stimulation on pain perception--an experimental study. Brain Stimul (2012) 0.91

Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature. Prim Care Companion CNS Disord (2013) 0.90

The economic burden of treatment-resistant depression. Clin Ther (2013) 0.90

Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry (2008) 0.89

Vagus nerve stimulation in refractory epilepsy: effects on pro- and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation (2010) 0.89

The effect of right vagus nerve stimulation on focal cerebral ischemia: an experimental study in the rat. Brain Stimul (2011) 0.89

Transcutaneous auricular vagus nerve stimulation as a complementary therapy for pediatric epilepsy: a pilot trial. Epilepsy Behav (2013) 0.88

3 Tesla MRI of patients with a vagus nerve stimulator: initial experience using a T/R head coil under controlled conditions. J Magn Reson Imaging (2010) 0.86

Transcutaneous vagus nerve stimulation: retrospective assessment of cardiac safety in a pilot study. Front Psychiatry (2012) 0.86

Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J Psychiatr Res (2004) 0.86

A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devices (Auckl) (2013) 0.85

The emerging use of technology for the treatment of depression and other neuropsychiatric disorders. Ann Clin Psychiatry (2011) 0.84

Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.84

An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation. Chin Med J (Engl) (2014) 0.84

Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats. Brain Stimul (2012) 0.83

J.L. Corning and vagal nerve stimulation for seizures in the 1880s. Neurology (2002) 0.83

The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: a preliminary report. Neuroimmunomodulation (2005) 0.83

The implantable neurocybernetic prosthesis system. Pacing Clin Electrophysiol (1991) 0.83

Interferon-α induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: implications of cellular mechanism of IFN-α-induced depression. Int J Neuropsychopharmacol (2012) 0.83

Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol (2009) 0.83

Inflammatory cytokines, growth factors, and depression. Curr Pharm Des (2012) 0.82

Effect of vagal nerve stimulation on systemic inflammation and cardiac autonomic function in patients with refractory epilepsy. Neuroimmunomodulation (2008) 0.82

Vagus nerve stimulation for epilepsy: A review of the peripheral mechanisms. Surg Neurol Int (2012) 0.81

Transcutaneous vagus nerve stimulation in tinnitus: a pilot study. Acta Otolaryngol (2012) 0.81

Academic exam stress and depressive mood are associated with reductions in exhaled nitric oxide in healthy individuals. Biol Psychol (2013) 0.79

Medicare patient experience with vagus nerve stimulation for treatment-resistant depression. J Med Econ (2012) 0.79

Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention. PLoS One (2012) 0.79

The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in children with refractory epilepsy: an exploratory study. Neuroimmunomodulation (2012) 0.79

Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation. Heart Fail Rev (2011) 0.79

Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression. Brain Stimul (2013) 0.78

Preliminary experience with a new system for vagus nerve stimulation for the treatment of refractory focal onset seizures. Epilepsy Behav (2013) 0.78

Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders. Int J Neuropsychopharmacol (2003) 0.78

Increase in nitric oxide levels and mitochondrial membrane potential in platelets of untreated patients with major depression. Psychiatry Res (2013) 0.77

Electroencephalographic correlates of paced breathing. Neuroreport (1993) 0.77

Mania following vagus nerve stimulation: a case report and review of the literature. Epilepsy Behav (2010) 0.76

The effects of stimulation parameters on clinical outcomes in patients with vagus nerve stimulation implants with major depression. J ECT (2013) 0.76

Neuromodulation for intractable headaches. Curr Pain Headache Rep (2014) 0.76